You have 9 free searches left this month | for more free features.

City

Hangzhou (1)

Condition

COVID-19 (1)

Hospitalized Patients (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 4 (1)

Sponsor

First People's Hospital of Hangzhou (1)

Shandong Provincial Hospital (1)

Collaborator

Central hospital Affiliated to Shandong First Medical University (1)

First People's Hospital of Lin'an District (1)

First People's Hospital of Yuhang District (1)

Gansu Provincial Hospital (1)

Hangzhou Cancer Hospital (1)

The Affiliated Hospital Of Southwest Medical University (1)

The Second Affiliated Hospital of Shandong First Medical University (1)

Intervention

nirmatrelvir-ritonavir (2)

azvudine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

nirmatrelvir-ritonavir

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Nirmatrelvir-ritonavir in Hospitalized Patients

Recruiting

Hospitalized Patients

Nirmatrelvir-Ritonavir

Hangzhou, Zhejiang, China

Changcheng Shi

Feb 26, 2023

COVID-19 Trial (Azvudine, Nirmatrelvir-Ritonavir)

Not yet recruiting

COVID-19

Azvudine
Nirmatrelvir-Ritonavir

(no location specified)

Jan 25, 2023